Objective To evaluate the association between prostate inflammation, metabolic syndrome (MetS), and postoperative lower urinary tract symptoms in patients treated with transurethral resection of the prostate (TURP). Methods From April 2011, a consecutive series of patients treated with TURP were prospectively included in this observational study. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) criteria. Patients were evaluated at baseline and 1 month postoperative with the International Prostate Symptom Score (IPSS), including the storage IPSS (sIPSS) and voiding IPSS (vIPSS) subscores, the Overactive Bladder questionnaire (OAB-q), and uroflowmetry. Prostate volume was evaluated at baseline. Complications were classified using the modified Clavien system. TURP specimens were examined to define grade, location, and extent of the inflammatory infiltrate according to the standardized classification system of chronic prostatitis and/or chronic pelvic pain syndrome. Results One hundred and thirty-one subjects were enrolled, in which 54 patients (41.3%) presented with MetS. No differences were observed in terms of preoperative prostate-specific antigen, OAB score, IPSS, vIPSS, sIPSS, Qmax, post void residual, and prostate volume in subjects with and without MetS. An incidence of postoperative complications of 10.6% was recorded: 79% were classified as Clavien type I or II; 21% Clavien IIIb. Of 131 subjects, 97 (74.1%) presented with an inflammatory infiltrate. Patients with MetS presented a high proportion of inflammatory infiltrates compared to patients without MetS (45 of 54; 83% vs 52 of 77; 67%, P =.01). Patients with prostate inflammation presented a 50% risk reduction of postoperative storage urinary symptoms. Conclusion We confirmed the association between MetS and prostate inflammation.Patients with inflammatory infiltrates mostly benefit from TURP, particularly regarding storage symptoms.

Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms / DE NUNZIO, Cosimo; Brassetti, Aldo; Gacci, Mauro; Finazzi Agrò, Enrico; Carini, Marco; Presicce, Fabrizio; Tubaro, Andrea. - In: UROLOGY. - ISSN 0090-4295. - 86:2(2015), pp. 359-367. [10.1016/j.urology.2015.04.048]

Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms

DE NUNZIO, Cosimo
;
BRASSETTI, ALDO;PRESICCE, FABRIZIO;TUBARO, ANDREA
2015

Abstract

Objective To evaluate the association between prostate inflammation, metabolic syndrome (MetS), and postoperative lower urinary tract symptoms in patients treated with transurethral resection of the prostate (TURP). Methods From April 2011, a consecutive series of patients treated with TURP were prospectively included in this observational study. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) criteria. Patients were evaluated at baseline and 1 month postoperative with the International Prostate Symptom Score (IPSS), including the storage IPSS (sIPSS) and voiding IPSS (vIPSS) subscores, the Overactive Bladder questionnaire (OAB-q), and uroflowmetry. Prostate volume was evaluated at baseline. Complications were classified using the modified Clavien system. TURP specimens were examined to define grade, location, and extent of the inflammatory infiltrate according to the standardized classification system of chronic prostatitis and/or chronic pelvic pain syndrome. Results One hundred and thirty-one subjects were enrolled, in which 54 patients (41.3%) presented with MetS. No differences were observed in terms of preoperative prostate-specific antigen, OAB score, IPSS, vIPSS, sIPSS, Qmax, post void residual, and prostate volume in subjects with and without MetS. An incidence of postoperative complications of 10.6% was recorded: 79% were classified as Clavien type I or II; 21% Clavien IIIb. Of 131 subjects, 97 (74.1%) presented with an inflammatory infiltrate. Patients with MetS presented a high proportion of inflammatory infiltrates compared to patients without MetS (45 of 54; 83% vs 52 of 77; 67%, P =.01). Patients with prostate inflammation presented a 50% risk reduction of postoperative storage urinary symptoms. Conclusion We confirmed the association between MetS and prostate inflammation.Patients with inflammatory infiltrates mostly benefit from TURP, particularly regarding storage symptoms.
2015
aged; humans; lower urinary tract symptoms; male; metabolic syndrome x; middle aged; prospective studies; prostatic hyperplasia; prostatitis; time factors; treatment outcome; transurethral resection of prostate; urology; medicine (all)
01 Pubblicazione su rivista::01a Articolo in rivista
Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms / DE NUNZIO, Cosimo; Brassetti, Aldo; Gacci, Mauro; Finazzi Agrò, Enrico; Carini, Marco; Presicce, Fabrizio; Tubaro, Andrea. - In: UROLOGY. - ISSN 0090-4295. - 86:2(2015), pp. 359-367. [10.1016/j.urology.2015.04.048]
File allegati a questo prodotto
File Dimensione Formato  
DeNunzio_Patients-With-Prostatic_2015.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 229.87 kB
Formato Adobe PDF
229.87 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/958863
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 19
social impact